Active Filter(s):
Details:
BAT6026 is a novel OX40 agonist antibody with enhanced antibody dependent cellular cytotoxicity. It is being evaluated in phase 1/2 clinical trials in combination with sodium chloride injection for the treatment of patients with moderate to severe atopic dermatitis.
Lead Product(s): Sodium Chloride
Therapeutic Area: Dermatology Product Name: BAT6026
Highest Development Status: Phase I/ Phase II Product Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 01, 2024
Details:
Enterade® (sodium chloride) advanced oncology formula (a plant-based amino acid beverage) helps in reducing adverse gastrointestinal side effects for patients undergoing cancer treatment.
Lead Product(s): Sodium Chloride,Potassium Chloride,Magnesium Chloride
Therapeutic Area: Gastroenterology Product Name: Enterade
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 27, 2023
Details:
The macrogol in Movicol (sodium chloride) binds with water and retains it in the bowel. This allows the water to rehydrate and bulk the stool to trigger renewed colonic activity.
Lead Product(s): Sodium Chloride,Sodium Bicarbonate,Potassium Chloride
Therapeutic Area: Gastroenterology Product Name: Movicol
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Goldman Sachs Asset Management
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Financing December 15, 2022
Details:
Norgine signed exclusive licence and distribution agreements with Faes Farma S.A., Pharmacare Limited T/A Aspen Pharmacare and Swixx Biopharma to provide worldwide exposure to PLENVU.
Lead Product(s): Potassium Chloride,Sodium Chloride,Ascorbic Acid
Therapeutic Area: Gastroenterology Product Name: Undisclosed
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Faes Farma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement February 12, 2020